Invention Grant
- Patent Title: Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein
-
Application No.: US14561573Application Date: 2014-12-05
-
Publication No.: US09931373B2Publication Date: 2018-04-03
- Inventor: Elena Dudich , Lydia Semenkova , Igor Dudich , Eduard Tatulov
- Applicant: Igor Dudich , Lydia Semenkova , Igor Dudich , Eduard Tatulov
- Agency: Berggren, Inc.
- Main IPC: C07K14/475
- IPC: C07K14/475 ; C12N1/16 ; C12N1/19 ; C12N15/10 ; C12N15/81 ; C12N15/09 ; C12P21/02 ; A61K38/17 ; A61K33/24 ; A61K45/06 ; C07K14/47 ; A61K8/64 ; A61Q19/08 ; C12N5/09 ; C12N5/10
Abstract:
Disclosed are pharmaceutical and synergistic compositions human recombinant alpha-fetoprotein expressed in eukaryotic cells for preparation of therapeutic agents for use in oncology, immunotherapy, stem cell therapy, and cosmetology and also for the diagnosis of cancer and embryogenic pathologies.
Public/Granted literature
- US20150105325A1 RECOMBINANT ALPHA-FETOPROTEIN AND COMPOSITIONS THEREOF Public/Granted day:2015-04-16
Information query
